Recent News

• 05.21.2025 - How SkyWater’s Technology Platforms are Advancing Biomedical Innovation
• 05.08.2025 - SkyWater Announces Participation in Upcoming Investor Conferences
• 05.08.2025 - Bridging the Gap: Overcoming Development Barriers in Biomedical Microelectronics
• 05.07.2025 - SkyWater Technology Reports First Quarter 2025 Results
• 05.05.2025 - Lowering Barriers to Silicon: Cadence Launches MPW Aggregation Service for SKY130
• 04.21.2025 - Microelectronics in Medicine: How Semiconductors are Powering Biomedical Breakthroughs
• 04.16.2025 - SkyWater Appoints Dr. Percy Gilbert as Senior Vice President of Engineering
• 04.14.2025 - SkyWater Technology to Announce First Quarter Financial Results on May 7, 2025
• 04.01.2025 - SkyWater Expands Board of Directors with Appointment of Timothy Baxter, Tammy Miller and Andy LaFrence

Recent Filings

• 05.13.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.08.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.07.2025 - 8-K Current report
• 05.07.2025 - EX-99.1 EX-99.1
• 04.08.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.08.2025 - DEF 14A Other definitive proxy statements
• 04.08.2025 - ARS Annual Report to Security Holders
• 04.04.2025 - 3 Initial statement of beneficial ownership of securities
• 04.04.2025 - 3 Initial statement of beneficial ownership of securities
• 04.04.2025 - 3 Initial statement of beneficial ownership of securities